India Stem Cell Markets, Competition Forecast & Opportunities, 2026
24 nov. 2020 04h53 HE
|
Research and Markets
Dublin, Nov. 24, 2020 (GLOBE NEWSWIRE) -- The "India Stem Cell Market by Product Type (Adult; Induced Pluripotent; Human Embryonic; Others), by Application (Regenerative Medicine Vs. Drug Discovery...
Mesoblast Reports 2015 Financial Year Results And Provides Update On Phase 3 Chronic Heart Failure Program
16 août 2015 20h28 HE
|
Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 16, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today reported its 2015 full financial year results, and provided an update on important...
American CryoStem Enters Into Definitive Term Sheet With Health Innovative Technology Corporation Limited
02 juil. 2014 08h30 HE
|
American CryoStem Corp.
EATONTOWN, N.J., July 2, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Announces Agreement With the nanoRANCH Division of UHV Technologies for Cancer Research Utilizing ATCELL(TM)
18 juin 2014 09h00 HE
|
American CryoStem Corp.
EATONTOWN, N.J., June 18, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...
American CryoStem Announces Breakthroughs in the Expansion and Lineage-Specific Differentiations of Adipose-Derived Stem Cells
24 avr. 2014 09h00 HE
|
American CryoStem Corp.
EATONTOWN, N.J., April 24, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading biotechnology developer and licensor of patented adipose tissue-based adult stem cell...
CEO Dr. Robin Smith of NeoStem to Discuss Agreement to Acquire California Stem Cell, Inc. Live Today on Clear Channel's "The Traders Network Show"
15 avr. 2014 07h15 HE
|
NeoStem, Inc.
NEW YORK, NY--(Marketwired - Apr 15, 2014) - NeoStem, Inc. (NASDAQ: NBS) ("NeoStem"), a leader in the emerging cellular therapy industry, announced today that Chairman and CEO, Dr. Robin Smith,...
American CryoStem and Rutgers University File Joint Patent on Adipose-Derived Stem Cell Platform Technology
10 avr. 2014 08h00 HE
|
American CryoStem Corp.
Combined Technologies Create Basis for Joint Development of
Multi-Functional Nanotechnology Platforms
EATONTOWN, N.J., April 10, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation...
American CryoStem Selected as "Incubator Company of the Year" by New Jersey Business Incubation Network (NJBIN)
09 avr. 2014 09h06 HE
|
American CryoStem Corp.
EATONTOWN, N.J., April 9, 2014 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading biotechnology developer and global licensor of patented adipose tissue-based adult stem cell...
American CryoStem Posts Letter to Shareholders
06 janv. 2014 13h45 HE
|
American CryoStem Corp.
EATONTOWN, N.J., Jan. 6, 2014 (GLOBE NEWSWIRE) -- John Arnone, Chairman and CEO of American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented...
American CryoStem and Protein Genomics Form Autogenesis Corporation to Support Development of Unique Stem Cell-Based Wound Products
14 nov. 2013 08h30 HE
|
American CryoStem Corp.
EATONTOWN, N.J., Nov. 14, 2013 (GLOBE NEWSWIRE) -- American CryoStem Corporation (OTCQB:CRYO), a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular...